Log out
to your PfizerFlex
Patient Support Program
for ABRILADA
Uveitis
Uveitis is a form of eye inflammation, causing redness, pain, light sensitivity, and blurred vision. It affects the middle layer of tissue in the eye wall (uvea). The condition can affect one or both eyes, and it can affect people of all ages, even children, but primarily adults between 20 and 50 years old. Possible causes of uveitis are infection, injury, or an autoimmune or inflammatory disease. Many times, a cause can't be identified.
ABRILADA is used to treat adults with uveitis and children with chronic non-infectious uveitis from 2 years of age.
The way ABRILADA works is by binding to a substance called TNF-alpha (which stands for tumour necrosis factor alpha) and reducing the risk of inflammation and vision loss in uveitis. However, ABRILADA can also lower the body’s ability to fight infections, and taking it can make you or your child more prone to getting infections, or make any infection worse.
ABRILADA is administered by injection under the skin, also called a subcutaneous injection.
ABRILADA ®, Pfizer Inc., owner/ Pfizer Canada ULC, Licensee
PFIZERFLEX TM, Pfizer Inc., owner/ Pfizer Canada ULC, Licensee
© 2024 Pfizer Canada ULC, Kirkland, Quebec H9J 2M5
PP-ABD-CAN-0037-EN